Biogen Idec reports today that Cecil Pickett, the biotech firm’s president of R&D, will be leaving his position on the board of directors when he retires on Oct. 5. This is a change from the March 2009 announcement of Pickett’s retirement, when the Cambridge, MA-based firm (NASDAQ:[[ticker:BIIB]]) said he would stay on the board after retiring from his executive role. Last month the company revealed that Biogen co-founder and Nobel laureate Phil Sharp was retiring from the company’s board.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
